Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages

Luca Galluzzi1, Aurora Diotallevi1, Mauro De Santi1

  • 1Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Plos One
|December 16, 2016
PubMed

Insights

Leishmania parasites induce mild endoplasmic reticulum (ER) stress in macrophages, promoting host cell survival by inhibiting apoptosis. This ER stress response may be a therapeutic target for leishmaniasis.

Area of Science:

  • Parasitology
  • Cell Biology
  • Immunology

Background:

  • Leishmania parasites cause leishmaniasis, evading host defenses by inhibiting apoptosis in infected macrophages.
  • Intracellular pathogens manipulate host cell organelles, like the endoplasmic reticulum (ER), to survive and replicate.
  • ER stress and the unfolded protein response (UPR) are critical in managing cellular stress, but prolonged stress can trigger apoptosis.

Purpose of the Study:

  • To investigate the ER stress response in macrophages infected with Leishmania infantum.
  • To understand the mechanisms behind apoptosis resistance in Leishmania-infected cells.

Main Methods:

  • Macrophages (human cell lines and murine primary) were infected with Leishmania infantum.
  • Gene expression of ER stress/autophagy markers and apoptosis markers (phospho-Akt, cleaved caspase-3) were analyzed using qPCR and Western blotting.
  • Cells were treated with ER stress inducers (tunicamycin, DTT) as positive controls.

Main Results:

  • Leishmania infection induced mild but significant increases in ER stress and autophagy markers.
  • Infection led to Akt phosphorylation and inhibited caspase-3 cleavage, eIF2α phosphorylation, and DDIT3/CHOP expression, even with ER stress inducers.
  • These findings suggest Leishmania infantum promotes host cell survival via a mild ER stress response.

Conclusions:

  • Leishmania infantum infection induces a mild ER stress response in macrophages, contributing to apoptosis resistance.
  • This ER stress modulation may be a conserved pathogenic mechanism across Leishmania species.
  • Targeting the host ER stress response presents a potential strategy for developing new anti-leishmaniasis drugs.

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...